Home
Department of Clinical Science

News archive for Department of Clinical Science

The Martens Group is proud to announce Niladri's successful defence of his PhD thesis entitled "An evolutionary epigenetics approach to schizophrenia." Niladri received main supervision by Stéphanie Le Hellard (UiB) and co-supervision by Timothy Hughes, (UiO), and Tatiana Polushina (UiB).
The Martens Group is very proud on behalf of Priyanthi's successful defence of her PhD thesis entitled “Lipid effects during antipsychotic drug treatment and their relevance for clinical outcomes.” Priyanthi received main supervision in her doctoral project from Vidar Steen (UiB) and co-supervision by Ingrid Melle (UiO), Erik Johnsen (UiB) and Silje Skrede (UiB).
As many as 50 per cent of women suffering from cardiac arrest are given insufficient treatment, because the heart failure was not caused by a heart attack.
As a child, Silke Appel was taken on ski trips to Geilo with her family from Berlin. Today she is a research director and deputy head of the Broegelmann Research Laboratory in Bergen, thanks to financial support from the Trond Mohn Foundation.
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.
You don’t only avoid holes in your teeth by keeping good oral hygiene, researchers at the University of Bergen have discovered a clear connection between gum disease and Alzheimer´s disease.
For the first time, researchers have shown that ordinary human cells can change their original function. The UiB-resarch published in Nature may give new hope for diabetes patients.
Researchers have found that neighbour-cells can take over functions of damaged or missing insulin-producing cells. The discovery may lead to new treatments for diabetes
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.
We reached a major milestone for our studies in the Norwegian Mother and Child Cohort study (MoBa).
New prototype launched at Ultradian consortium meeting
The Ultradian project is now on Twitter.
The Ultradian Platform for Metabolomics at the University of Bergen has completed the development of the 3rd Generation Steroid Hormone Assay.
Professor Per Eystein Lønning and his research team will map tumour genes for better and tailor made chemotherapy.
Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.

Pages